Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

Emil Lou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-1607-1386; OpenAlex author ID A5062667375. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
73
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 4 papers · 2023: 1 paper · 2024: 1 paper · 2025: 3 papers

Papers 13

  1. SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multic… Co-author DOI 10.1097/sla.0000000000006966↗
  2. Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-3149↗
  3. Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 St… Co-author DOI 10.1200/jco-25-00746↗
  4. Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational s… Last author DOI 10.1016/j.esmogo.2024.100042↗
  5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations … Co-author DOI 10.1158/1078-0432.ccr-22-3724↗
  6. Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-21-3581↗
  7. Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. Co-author DOI 10.1158/1078-0432.ccr-22-0275↗
  8. The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With No… Co-author DOI 10.1177/10732748221109991↗
  9. Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic Analysis. Co-author DOI 10.2196/31388↗
  10. Early detection of pancreatic cancer: current state and future opportunities. First author DOI 10.1097/mog.0000000000000770↗
  11. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival. Co-author DOI 10.1245/s10434-019-07602-6↗
  12. Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer. Last author DOI 10.1038/s41598-018-27649-x↗
  13. Pancreatic cancer: modulation of KRAS, MicroRNAs, and intercellular communication in the setting of tumor heterogeneity. Co-author DOI 10.1097/mpa.0000000000000007↗

Closest collaborators

The 25 strongest of 73 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anthony Frank Shields · 4 shared papers, 2022–2025 · strength 0.61
  2. Jashodeep Datta · 2 shared papers, 2025 · strength 0.40
  3. Wolfgang Michael Korn · 3 shared papers, 2022–2023 · strength 0.38
  4. Rachna T. Shroff · 2 shared papers, 2023–2025 · strength 0.37
  5. Anirban Maitra · 2 shared papers, 2021–2022 · strength 0.36
  6. Davendra P. S. Sohal · 2 shared papers, 2022–2024 · strength 0.29
  7. Wafik S. El‐Deiry · 2 shared papers, 2022–2024 · strength 0.29
  8. Andreas Seeber · 2 shared papers, 2022–2024 · strength 0.28
  9. Heinz‐Josef Lenz · 2 shared papers, 2022–2024 · strength 0.28
  10. Eric Hans Jensen · 2 shared papers, 2019–2022 · strength 0.24
  11. Jason W. Denbo · 2 shared papers, 2019–2022 · strength 0.24
  12. Schelomo Marmor · 2 shared papers, 2019–2022 · strength 0.24
  13. Ariella M. Altman · 2 shared papers, 2019–2022 · strength 0.24
  14. Michael J. Hall · 2 shared papers, 2022 · strength 0.23
  15. John Lindsay Marshall · 2 shared papers, 2022 · strength 0.23
  16. Harshabad Singh · 1 shared paper, 2025 · strength 0.21
  17. Bach Ardalan · 1 shared paper, 2025 · strength 0.21
  18. Andrew J. Aguirre · 1 shared paper, 2025 · strength 0.21
  19. Anup Kasi · 1 shared paper, 2025 · strength 0.21
  20. Michael Jon Pishvaian · 1 shared paper, 2025 · strength 0.21
  21. Aaron Ciner · 1 shared paper, 2025 · strength 0.21
  22. Sanjay Goel · 1 shared paper, 2025 · strength 0.21
  23. Julia Button · 1 shared paper, 2025 · strength 0.19
  24. Erin M. Dickey · 1 shared paper, 2025 · strength 0.19
  25. David G. Brauer · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.